Solventum SOLV
NYSE SOLV
$86.40 +1.35 (+1.59%)
As of: Oct 20, 2026 · 2:57 PM EDT

Solventum (SOLV) Capital Leases (2026)

Updated

Solventum (SOLV) recorded Capital Leases of $207 million in Q2 2026, unchanged from the prior quarter.

Analysis

Solventum (SOLV) Capital Leases (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 256.80 Bn 235.83 Bn 4.88 Bn
2 Abbott Laboratories 176.14 Bn 146.57 Bn 7.27 Bn
3 Danaher 158.45 Bn 142.25 Bn 3.61 Bn
4 Intuitive Surgical 155.08 Bn 134.50 Bn 1.96 Bn
5 Medtronic 120.69 Bn 85.94 Bn 6.34 Bn
6 Stryker 116.29 Bn 102.41 Bn 4.50 Bn
7 Boston Scientific 66.87 Bn 61.64 Bn 3.85 Bn
8 Becton Dickinson 53.10 Bn 50.25 Bn 2.32 Bn
9 Edwards Lifesciences 50.77 Bn 34.78 Bn 1.35 Bn
10 Solventum 14.93 Bn 11.44 Bn 1.29 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 207.00 Mn
Mar 31, 2026 207.00 Mn
API Access

Solventum Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=SOLV&period=max&api_key=YOUR_API_KEY